Alpine Immune Sciences
Presence
Alpine Immune Sciences is one of the...
Alpine Immune Sciences is a company listed under the stock ticker ALPN (US).
Acquisition, funding and merger involving Alpine Immune Sciences.
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Alpine Immune Sciences
- Mitchell Gold, Executive Chairman of the Board and Chief Executive...
- James Topper, Director
- Robert Conway, Director
Popular executive movements at Alpine Immune Sciences
- Wolfgang Dummer has joined the company as Chief Medical Officer (posted on October 5 2023).
- Christina Yi has joined the company as Chief Technology Officer (posted on August 23 2023).
Create your alert
to follow the executive moves at Alpine Immune Sciences.
Biotechnology
Alpine Immune Sciences has 2,282 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Alpine Immune Sciences
- Alpine Immune Sciences Announces Poster Presentation at 2020 Crohn’s & Colitis Congress | Alpine Immune Sciences
- Alpine Immune Sciences Presents ALPN-101 Phase 1 Healthy Volunteer Study Data and Details of Upcoming Phase I/II BALANCE GVHD Study at the 61st American Society of Hematology Annual Meeting | Alpine Immune Sciences
- Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2019 Financial Results | Alpine Immune Sciences
- Alpine Immune Sciences Presents New ALPN-101 Preclinical Data at the 2019 American College of Rheumatology (ACR) Annual Meeting | Alpine Immune Sciences
- Alpine Immune Sciences Presents New Preclinical Data at The Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting | Alpine Immune Sciences
- Alpine Immune Sciences Announces Oral Presentation of ALPN-101 at the 61st American Society of Hematology Annual Meeting and Exposition | Alpine Immune Sciences
- Alpine Immune Sciences to Present at Upcoming Investor Conferences | Alpine Immune Sciences
- Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products | Alpine Immune Sciences
- Alpine Immune Sciences Completes Enrollment of Phase I Study of ALPN-101 and Announces Third Quarter Conference Call | Alpine Immune Sciences
- Alpine Immune Sciences to Present at 2019 Wedbush PacGrow Healthcare Conference | Alpine Immune Sciences
- View more press releases Close
Social media about Alpine Immune Sciences
- Alpine Immune Sciences on Wikipedia, Google News & Yahoo Finance
- Alpine Immune Sciences on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Mitchell Gold 
Call Alpine Immune Sciences at +1 206...
